FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1088411000001108: Co-amilozide 2.5mg/25mg tablets 100 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21475101000001114 Co-amilozide 2.5mg/25mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21475201000001119 Co-amilozide 2.5mg/25mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amilozide 2.5mg/25mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Is pack of Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has active ingredient Amiloride hydrochloride false Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has VMP Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has specific active ingredient Amiloride hydrochloride true Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-amilozide 2.5mg/25mg tablets (Kent Pharma (UK) Ltd) 100 tablet Is a True Co-amilozide 2.5mg/25mg tablets 100 tablet Inferred relationship Existential restriction modifier
Synuretic 25 tablets (Dr Reddy's Labs) 100 tablet Is a True Co-amilozide 2.5mg/25mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets (Unichem Plc) 100 tablet Is a True Co-amilozide 2.5mg/25mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start